These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26315255)

  • 1. The incidence and sites of Nasopharyngeal carcinoma (NPC) metastases on FDG PET/CT scans.
    Al Tamimi AS; Zaheer S; Ng DC; Osmany S
    Oral Oncol; 2015 Nov; 51(11):1047-1050. PubMed ID: 26315255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of 18F-FDG PET/CT on assessment of nasopharyngeal carcinoma at diagnosis.
    King AD; Ma BB; Yau YY; Zee B; Leung SF; Wong JK; Kam MK; Ahuja AT; Chan AT
    Br J Radiol; 2008 Apr; 81(964):291-8. PubMed ID: 18344274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body
    Ren YY; Li YC; Wu HB; Wang QS; Han YJ; Zhou WL; Li HS
    Eur J Radiol; 2017 Apr; 89():200-207. PubMed ID: 28267540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography.
    Chang JT; Chan SC; Yen TC; Liao CT; Lin CY; Lin KJ; Chen IH; Wang HM; Chang YC; Chen TM; Kang CJ; Ng SH
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):501-7. PubMed ID: 15890593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of tailoring whole-body dual-modality [18F]fluorodeoxyglucose positron emission tomography/computed tomography with plasma Epstein-Barr virus DNA for detecting distant metastasis in endemic nasopharyngeal carcinoma at initial staging.
    Tang LQ; Chen QY; Fan W; Liu H; Zhang L; Guo L; Luo DH; Huang PY; Zhang X; Lin XP; Mo YX; Liu LZ; Mo HY; Li J; Zou RH; Cao Y; Xiang YQ; Qiu F; Sun R; Chen MY; Hua YJ; Lv X; Wang L; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Mai HQ
    J Clin Oncol; 2013 Aug; 31(23):2861-9. PubMed ID: 23857969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx.
    Yen TC; Chang JT; Ng SH; Chang YC; Chan SC; Lin KJ; Lin WJ; Fu YK; Lin CY
    J Nucl Med; 2005 Mar; 46(3):405-10. PubMed ID: 15750151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDG PET/CT in the management of nasopharyngeal carcinoma.
    Mohandas A; Marcus C; Kang H; Truong MT; Subramaniam RM
    AJR Am J Roentgenol; 2014 Aug; 203(2):W146-57. PubMed ID: 25055290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
    Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
    J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
    Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
    Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of diagnostic value of 18F-FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma.
    Shen G; Zhang W; Jia Z; Li J; Wang Q; Deng H
    Br J Radiol; 2014 Dec; 87(1044):20140296. PubMed ID: 25348201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy].
    Yu DF; Zuo CT; Dai JZ; Dong MJ; Zhao J; Lin XT; Guan YH
    Ai Zheng; 2004 Nov; 23(11 Suppl):1538-41. PubMed ID: 15566675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-Tesla and FDG-PET-CT.
    Ng SH; Chan SC; Yen TC; Chang JT; Liao CT; Ko SF; Wang HM; Wai YY; Wang JJ; Chen MC
    Eur Radiol; 2009 Dec; 19(12):2965-76. PubMed ID: 19588148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
    Iagaru A; Mittra ES; Gambhir SS
    Mol Imaging Biol; 2011 Apr; 13(2):362-7. PubMed ID: 20495879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical application of (18)F-FDG PET/CT to staging and treatment effectiveness monitoring of nasopharyngeal carcinoma].
    Wang GH; Lau EW; Shakher R; Binns DS; Hogg A; Drummond E; Hicks RJ
    Ai Zheng; 2007 Jun; 26(6):638-42. PubMed ID: 17562272
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Al Tamimi AS; Zaheer S; Ng DC; Osmany S
    World J Nucl Med; 2017; 16(3):192-196. PubMed ID: 28670176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
    Senft A; de Bree R; Hoekstra OS; Kuik DJ; Golding RP; Oyen WJ; Pruim J; van den Hoogen FJ; Roodenburg JL; Leemans CR
    Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is unenhanced 18F-FDG-PET/CT better than enhanced CT in the detection of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma?
    Wu IS; Hung GU; Chang BL; Liu CK; Chang TH; Lee HS; Chen MK
    Ear Nose Throat J; 2016; 95(4-5):178-84. PubMed ID: 27140019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma.
    Yen RF; Hong RL; Tzen KY; Pan MH; Chen TH
    J Nucl Med; 2005 May; 46(5):770-4. PubMed ID: 15872349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET/CT for staging and follow-up of pediatric nasopharyngeal carcinoma.
    Cheuk DK; Sabin ND; Hossain M; Wozniak A; Naik M; Rodriguez-Galindo C; Krasin MJ; Shulkin BL
    Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1097-106. PubMed ID: 22532252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
    Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.